Although previous studies have proved that MSCs can differentiate into β-cells or insulin-producing cells in vitro [48–50], it is increasingly evidenced that limited transdifferentiation of the infused MSCs could occur in vivo to facilitate the process of pancreas regeneration and ameliorate hyperglycemia in T2DM models. The gene discussed is INS; the disease is type 2 diabetes mellitus.